88 related articles for article (PubMed ID: 3262060)
1. Bovine endothelial cell plasminogen activator inhibitor. Purification and heat activation.
Katagiri K; Okada K; Hattori H; Yano M
Eur J Biochem; 1988 Sep; 176(1):81-7. PubMed ID: 3262060
[TBL] [Abstract][Full Text] [Related]
2. Kinetic analysis of the interactions between plasminogen activator inhibitor 1 and both urokinase and tissue plasminogen activator.
Hekman CM; Loskutoff DJ
Arch Biochem Biophys; 1988 Apr; 262(1):199-210. PubMed ID: 3128176
[TBL] [Abstract][Full Text] [Related]
3. Immunoaffinity purification of HTC rat hepatoma cell plasminogen activator-inhibitor-1.
Zeheb R; Rafferty UM; Rodriguez MA; Andreasen P; Gelehrter TD
Thromb Haemost; 1987 Dec; 58(4):1017-23. PubMed ID: 3127913
[TBL] [Abstract][Full Text] [Related]
4. Bovine plasminogen activator inhibitor 1: specificity determinations and comparison of the active, latent, and guanidine-activated forms.
Hekman CM; Loskutoff DJ
Biochemistry; 1988 Apr; 27(8):2911-8. PubMed ID: 2969749
[TBL] [Abstract][Full Text] [Related]
5. Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by denaturants.
Hekman CM; Loskutoff DJ
J Biol Chem; 1985 Sep; 260(21):11581-7. PubMed ID: 3930479
[TBL] [Abstract][Full Text] [Related]
6. Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin).
Declerck PJ; De Mol M; Alessi MC; Baudner S; Pâques EP; Preissner KT; Müller-Berghaus G; Collen D
J Biol Chem; 1988 Oct; 263(30):15454-61. PubMed ID: 2459123
[TBL] [Abstract][Full Text] [Related]
7. Conversion of the active to latent plasminogen activator inhibitor from human endothelial cells.
Levin EG; Santell L
Blood; 1987 Oct; 70(4):1090-8. PubMed ID: 3498518
[TBL] [Abstract][Full Text] [Related]
8. Purification and characterization of natural and recombinant human plasminogen activator inhibitor-1 (PAI-1).
Alessi MC; Declerck PJ; De Mol M; Nelles L; Collen D
Eur J Biochem; 1988 Aug; 175(3):531-40. PubMed ID: 3261688
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen activator inhibitor type 1 production by rat type II pneumocytes in culture.
Parton LA; Warburton D; Laug WE
Am J Respir Cell Mol Biol; 1992 Feb; 6(2):133-9. PubMed ID: 1540377
[TBL] [Abstract][Full Text] [Related]
10. Purification of an active plasminogen activator inhibitor immunologically related to the endothelial type plasminogen activator inhibitor from the conditioned media of a human melanoma cell line.
Wagner OF; Vetterlein M; Binder BR
J Biol Chem; 1986 Nov; 261(31):14474-81. PubMed ID: 3490474
[TBL] [Abstract][Full Text] [Related]
11. Association of a plasminogen activator inhibitor (PAI-1) with the growth substratum and membrane of human endothelial cells.
Levin EG; Santell L
J Cell Biol; 1987 Dec; 105(6 Pt 1):2543-9. PubMed ID: 3121634
[TBL] [Abstract][Full Text] [Related]
12. Purification of high and low molecular weight plasminogen activator inhibitor 1 from fibrosarcoma cell-line HT 1080 conditioned medium.
Lindahl T; Wiman B
Biochim Biophys Acta; 1989 Feb; 994(3):253-7. PubMed ID: 2493266
[TBL] [Abstract][Full Text] [Related]
13. The dexamethasone-induced inhibitor of plasminogen activator in hepatoma cells is antigenically-related to an inhibitor produced by bovine aortic endothelial cells.
Loskutoff DJ; Roegner K; Erickson LA; Schleef RR; Huttenlocher A; Coleman PL; Gelehrter TD
Thromb Haemost; 1986 Feb; 55(1):8-11. PubMed ID: 3486492
[TBL] [Abstract][Full Text] [Related]
14. Denaturant-induced stimulation of the beta-migrating plasminogen activator inhibitor in endothelial cells and serum.
Erickson LA; Hekman CM; Loskutoff DJ
Blood; 1986 Dec; 68(6):1298-305. PubMed ID: 2430646
[TBL] [Abstract][Full Text] [Related]
15. Purification of active human plasminogen activator inhibitor 1 from Escherichia coli. Comparison with natural and recombinant forms purified from eucaryotic cells.
Lawrence D; Strandberg L; Grundström T; Ny T
Eur J Biochem; 1989 Dec; 186(3):523-33. PubMed ID: 2514093
[TBL] [Abstract][Full Text] [Related]
16. The formation of complexes between human plasminogen activator inhibitor-1 (PAI-1) and sodium dodecyl sulfate: possible implication in the functional properties of PAI-1.
Gaussem P; Anglés-Cano E
Biochim Biophys Acta; 1991 Sep; 1079(3):321-9. PubMed ID: 1911857
[TBL] [Abstract][Full Text] [Related]
17. Retinal pigment epithelial cells produce a latent fibrinolytic inhibitor that is antigenically and biochemically related to type 1 plasminogen activator inhibitor produced by vascular endothelial cells.
Campochiaro PA; Mimuro J; Sugg R; Loskutoff DJ
Exp Eye Res; 1989 Aug; 49(2):195-203. PubMed ID: 2504614
[TBL] [Abstract][Full Text] [Related]
18. Affinity purification of active plasminogen activator inhibitor-1 (PAI-1) using immobilized anhydrourokinase. Demonstration of the binding, stabilization, and activation of PAI-1 by vitronectin.
Wun TC; Palmier MO; Siegel NR; Smith CE
J Biol Chem; 1989 May; 264(14):7862-8. PubMed ID: 2470735
[TBL] [Abstract][Full Text] [Related]
19. Presence of active and latent type 1 plasminogen activator inhibitor associated with porcine platelets.
Lang IM; Marsh JJ; Moser KM; Schleef RR
Blood; 1992 Nov; 80(9):2269-74. PubMed ID: 1421397
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activator inhibitor from human endothelial cells. Purification and partial characterization.
Booth NA; MacGregor IR; Hunter NR; Bennett B
Eur J Biochem; 1987 Jun; 165(3):595-600. PubMed ID: 3496217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]